Label: ALMOND- prunus dulcis injection, solution
APPLE- malus domestica injection, solution
APRICOT- prunus armeniaca injection, solution
ASPARAGUS- asparagus officinalis injection, solution
AVOCADO- persea americana injection, solution
BANANA- musa sapientum injection, solution
TURKEY- meleagris gallopavo injection, solution
VANILLA- vanilla planifolia injection, solution
VITIS SPP injection, solution
WATERMELON- citrullus lanatus injection, solution
WHEAT GRAIN- triticum aestivum injection, solution
WHITE POTATO- solanum tuberosum injection, solution

  • NDC Code(s): 0268-6100-06, 0268-6100-10, 0268-6101-06, 0268-6101-10, view more
    0268-6102-06, 0268-6102-10, 0268-6103-06, 0268-6103-10, 0268-6104-06, 0268-6104-10, 0268-6105-06, 0268-6105-10, 0268-6106-06, 0268-6106-10, 0268-6107-06, 0268-6107-10, 0268-6108-06, 0268-6108-10, 0268-6109-06, 0268-6109-10, 0268-6110-06, 0268-6110-10, 0268-6112-06, 0268-6112-10, 0268-6113-06, 0268-6113-10, 0268-6114-06, 0268-6114-10, 0268-6115-06, 0268-6115-10, 0268-6116-06, 0268-6116-10, 0268-6118-06, 0268-6118-10, 0268-6120-06, 0268-6120-10, 0268-6121-06, 0268-6121-10, 0268-6122-06, 0268-6122-10, 0268-6123-06, 0268-6123-10, 0268-6124-06, 0268-6124-10, 0268-6125-06, 0268-6125-10, 0268-6127-06, 0268-6127-10, 0268-6128-06, 0268-6128-10, 0268-6129-06, 0268-6129-10, 0268-6130-06, 0268-6130-10, 0268-6132-06, 0268-6132-10, 0268-6133-06, 0268-6133-10, 0268-6135-06, 0268-6135-10, 0268-6136-06, 0268-6136-10, 0268-6137-06, 0268-6137-10, 0268-6138-06, 0268-6138-10, 0268-6139-06, 0268-6139-10, 0268-6141-06, 0268-6146-06, 0268-6146-10, 0268-6149-06, 0268-6149-10, 0268-6170-06, 0268-6170-10, 0268-6171-06, 0268-6171-10, 0268-6173-06, 0268-6173-10, 0268-6174-06, 0268-6174-10, 0268-6177-06, 0268-6177-10, 0268-6178-06, 0268-6178-10, 0268-6180-06, 0268-6180-10, 0268-6181-06, 0268-6181-10, 0268-6183-06, 0268-6183-10, 0268-6185-06, 0268-6185-10, 0268-6186-06, 0268-6186-10, 0268-6187-06, 0268-6187-10, 0268-6189-06, 0268-6189-10, 0268-6191-06, 0268-6191-10, 0268-6192-06, 0268-6192-10, 0268-6193-06, 0268-6193-10, 0268-6195-06, 0268-6195-10, 0268-6196-06, 0268-6196-10, 0268-6197-06, 0268-6197-10, 0268-6198-06, 0268-6198-10, 0268-6200-06, 0268-6200-10, 0268-6202-06, 0268-6202-10, 0268-6203-06, 0268-6203-10, 0268-6204-06, 0268-6204-10, 0268-6205-06, 0268-6205-10, 0268-6206-06, 0268-6206-10, 0268-6208-06, 0268-6208-10, 0268-6210-06, 0268-6210-10, 0268-6212-06, 0268-6212-10, 0268-6213-06, 0268-6213-10, 0268-6214-06, 0268-6214-10, 0268-6216-06, 0268-6216-10, 0268-6218-06, 0268-6218-10, 0268-6219-06, 0268-6219-10, 0268-6220-06, 0268-6220-10, 0268-6221-06, 0268-6221-10, 0268-6224-06, 0268-6224-10, 0268-6226-06, 0268-6226-10, 0268-6229-06, 0268-6229-10, 0268-6230-06, 0268-6230-10, 0268-6231-06, 0268-6231-10, 0268-6233-06, 0268-6233-10, 0268-6234-06, 0268-6234-10, 0268-6235-06, 0268-6235-10, 0268-6236-10, 0268-7130-06, 0268-8043-06, 0268-8044-10, 0268-8061-06, 0268-8062-10
  • Packager: ALK-Abello, Inc.
  • Category: NON-STANDARDIZED ALLERGENIC LABEL
  • DEA Schedule: None
  • Marketing Status: Biologic Licensing Application

Drug Label Information

Updated December 8, 2021

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    ALLERGENIC EXTRACTS,

    FOR DIAGNOSTIC USE ONLY

    DIRECTIONS FOR USE

  • BOXED WARNING (What is this?)

    WARNING

    This product is intended for use by physicians who are experienced in the administration of allergenic extracts and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist.

    As with all allergenic extracts, severe systemic reactions may occur. In certain individuals these life-threatening reactions may result in death. Fatalities associated with skin testing have been reported. Patients should be observed for at least 20 - 30 minutes following testing. Emergency measures and adequately trained personnel should be immediately available in the event of a life-threatening reaction.

    Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater risk to a fatal outcome from a systemic allergic reaction.

    Sensitive patients may experience severe anaphlactic reactions resulting in respiratory obstruction, shock, coma and/or death. Adverse events are to be reported to MedWatch (1-800-FDA-1088), Adverse Event Reporting, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20852-9787. This product should not be injected intravenously. Patients receiving beta blockers may not be responsive to epinephrine or inhaled bronchodilators. Respiratory obstruction not responding to parenteral or inhaled bronchodilators may require theophylline, oxygen, intubation and the use of life support systems. Parenteral fluid and/or plasma expanders may be utilized for the treatment of shock. Adrenocorticosteroids may be administered parenterally or intravenously. Refer to WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections below.

  • SPL UNCLASSIFIED SECTION

    Port Washington, NY 11050

    U.S. Government License No. 1256

  • DESCRIPTION

    Sterile diagnostic extracts are supplied in either phenol-saline diluent for Intradermal Testing or in diluent containing glycerin 50% (v/v) for Percutaneous Testing and phenol 0.4% (preservative). Inactive ingredients may include: sodium chloride for isotonicity, glycerin, and sodium bicarbonate as a bufferPollens are individually extracted from pure pollen extracted in a phenol-preserved sodium bicarbonate solution. Short Ragweed and Mixed (Tall and Short) Ragweed extracts are standardized by Antigen E content and so labeled. The Antigen E content of extracts containing Short Ragweed at a concentration more dilute than a weight/volume ratio of 1:10 are obtained by calculating the Antigen E content based on the assay value of more concentrated extract. Pollen extracts are filtered aseptically and after final packaging, they are tested for sterility and safety. Molds are individually extracted from pure powdered inactivated mold source material extracted in phenol preserved saline.Mold extracts are filtered aseptically and after final packaging are tested for sterility and safety.

    Molds (fungi) are present in all inhabited places at all seasons of the year; they are so ubiquitous that they are prevalent at times when common allergic pollens and other inhalants are not. In the home and surroundings, molds are found in upholstered furniture, mattresses, drapes, cellar and storage room dust, woolens, leather goods, fruits, meats, cheeses, garden soil and on plants. Spores, mycelial fragments and mold residues are thus inhaled, contacted and ingested continuously.

    Foods, miscellaneous inhalants and epidermals are individually extracted in phenol preserved saline or glycerin, filtered aseptically and after final packaging are tested for sterility and safety.

  • CLINICAL PHARMACOLOGY

    Diagnostically (for skin testing) the allergen combines with IgE antibodies fixed to mast cells in the skin. This complexing causes an increase in cellular permeability and degranulation of the mast cells releasing chemical mediators. These mediators (such as histamine) are responsible for a local inflammatory response of wheal and erythema typical of a positive skin test reaction and also, the symptoms commonly associated with allergic disease.1 The more mediator release, the larger the reaction (wheal and erythema).

  • INDICATIONS AND USAGE

    These products are for diagnostic use only. Diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. By measuring skin test response the physician may assess the degree of sensitivity that patients have to the allergens. For extracts standardized in AU and BAU, see individual directions for use. Allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use.

  • CONTRAINDICATIONS

    Patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed WARNING statement and ADVERSE REACTIONS). The physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise.

    Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater risk to a fatal outcome from a systemic allergic reaction2,3. See also PRECAUTIONS and ADVERSE REACTIONS.

  • WARNING

    Patients should always be observed for at least 20 - 30 minutes after skin testing. In the event of a marked systemic reaction such as urticaria, angioedema, wheezing, dyspnea, respiratory obstruction, hypotension, coma and death (see ADVERSE REACTIONS), applications of a tourniquet above the injection site and administration of 0.2 mL to 1 mL (0.01 mg/kg) of epinephrine injection (1:1,000) are recommended. Maximal recommended dose for children between 2 and 12 years of age is 0.5 mL. The tourniquet is then gradually released at 15 minute intervals. Patients under treatment with beta blockers may be refractory to the usual dose of epinephrine.

    Volume expanders and vasopressor agents may be required to reverse hypotension, inhalation bronchodilators and parenteral aminophylline may be required to reverse bronchospasm. In case of respiratory obstruction, oxygen and intubation may be necessary. Life-threatening reactions unresponsive to the above may require cardiopulmonary resuscitation.

  • PRECAUTIONS

  • INFORMATION FOR PATIENTS:

    Patients should be instructed to describe any active allergic symptoms such as rhinitis, wheezing, dyspnea, etc. prior to testing. Also, see ADVERSE REACTIONS and WARNINGS Sections.

    Patients should always be observed 20 to 30 minutes after testing.

    General:

    1. In the presence of active symptoms such as rhinitis, wheezing, dyspnea, etc., the indications for skin testing must be weighed carefully against the risk of temporarily aggravating the symptoms by the testing itself. Objective assessment of pulmonary function such as Peak Expiratory Flow Rate (PEFR) before allergen administration and prior to discharge may be useful in unstable asthmatics to reduce the chances of exacerbation of the patient’s asthma. Patients should be instructed to describe any active allergic symptoms as described above prior to skin testing and encouraged to report any late reactions from this testing. Also, see ADVERSE REACTIONS and WARNING sections.
    2. Store allergenic extracts between 2°-8°C at all times, even during use.
    3. Care must be taken to avoid drawing blood.
      1. For percutaneous testing, if blood is observed, immediately wipe the allergen from the site.
      2. For intradermal skin testing, pull gently on the syringe plunger and note if any blood enters the syringe. If blood is obtained, reposition the needle and repeat before injecting (see DOSAGE AND ADMINISTRATION).

    4. Allergenic extracts become less potent with age. Allergenic extracts containing glycerin 50% v/v are relatively stable. Non-glycerinated aqueous extracts, particularly dilute forms as used for intradermal skin testing, have been shown to be extremely unstable. Until such time as stability studies are complete with dilute allergens, new intradermal strength materials should be prepared every few weeks.
    5. Use standard aseptic precautions if making dilutions from stock concentrates to intradermal strength.
    6. For intradermal testing: Extracts in glycerin 50% v/v must be diluted with a non-glycerinated diluent and must be diluted at least 25-fold to less than 2% glycerin by volume, as glycerin above this level can cause false positive intradermal skin test results.

    Pregnancy - Category C: 

    Animal reproduction studies have not been conducted with allergenic extracts. It is also not known whether allergenic extracts can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

    Controlled studies of hyposensitization with moderate to high doses of allergenic extracts during conception and all trimesters of pregnancy have failed to demonstrate any risk to the fetus or to the mother4. However, on the basis of histamine’s known ability to contract the uterine muscle, the release of significant amounts of histamine from allergen exposure to skin test overdose should be avoided on theoretical grounds. Therefore, allergenic extracts should be used cautiously in a pregnant woman and only if clearly needed.

    Pediatric Use:

    Allergenic extracts for diagnostic use have been given safely in infants and young children. Infants have lower skin test reactivity to histamine, as well as common allergens. Skin test reactivity gradually increases to age 6 and plateaus to age 60. Therefore, small skin test reactions should be anticipated in children under age 6.

    Geriatric Use: 

    Skin test reactivity gradually decreases after age 60. Therefore, smaller skin test reactions should be anticipated in adults over age 60.

    Nursing Mothers: 

    It is not known if allergens administered subcutaneously appear in human milk. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman.

    Carcinogenesis, mutagenesis, impairment of fertility: 

    Studies in animals have not been performed.

    Drug Interactions:

    Drugs can interfere with the performance of skin tests5.

    Antihistamines: Response to mediator (histamine) released by allergens is suppressed by antihistamines. The length of suppression varies and is dependent on individual patient, type of antihistamine and length of time the patient has been on antihistamines. The duration of this suppression may be as little as 24 hours (chlorpheniramine), and can be as long as 40 days (astemizole).

    Tricyclic Antidepressants: These exert a potent and sustained decrease of skin reactivity to histamine which may last for a few weeks.

    Beta2 Agonists: Oral terbutaline and parenteral ephedrine, in general, have been shown to decrease allergen induced wheal.

    Dopamine: Intravenous infusion of dopamine may inhibit skin test responses.

    Beta Blocking Agents: Propranolol can significantly increase skin test reactivity.

    Other Drugs: Short acting steroids, inhaled beta2 agonists, theophylline and cromolyn do not seem to affect skin test response.

  • ADVERSE REACTIONS

    Fatalities from skin testing in the United States have been extensively reviewed by Lockey.2 Six fatalities were associated with intradermal testing without previous percutaneous testing and one was associated with a combination of percutaneous (scratch) and intradermal skin testing. With careful attention to dosage and administration, fatal reactions occur infrequently, but it must be remembered that allergenic extracts are highly potent to sensitive individuals and overdosage could result in anaphylactic symptoms. Therefore it is imperative that physicians administering allergenic extracts for skin testing understand, and be prepared for the treatment of severe reactions.

    Local:

    Immediate wheal and erythema reactions are to be expected; but if very large, may be the first manifestation of a systemic reaction. In such cases, immediately wipe the test site(s) with sterile gauze or cotton to remove excess allergen.

    Systemic Reactions: 

    Systemic reactions are characterized by one or more of the following symptoms: sneezing, mild to severe generalized urticaria, itching (other than at the skin test site), extensive or generalized edema, wheezing, asthma, dyspnea, cyanosis, hypotension, syncope, and upper airway obstruction. Symptoms may progress to shock and death. Patients should always be observed for at least 20 - 30 minutes after testing.

    Volume expanders and vasopressor agents may be required to reverse hypotension. Inhalational bronchodilators and parenteral aminophylline may be required to reverse bronchospasm. Severe airway obstruction unresponsive to bronchodilator may require tracheal intubation and use of oxygen. In the event of a marked systemic reaction, application of a tourniquet above the injection site and the administration of 0.2 mL to 1.0 mL of epinephrine injection (1:1,000) is recommended. Maximum recommended dose for children between 2 and 12 years of age is 0.3 mL. The tourniquet should not be left in place without loosening for 90 seconds every 15 minutes.

    Adverse events should be reported via MedWatch (1-800-FDA-1088), Adverse Event Reporting, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20852-9787.

  • OVERDOSAGE

    Signs and symptoms of overdose are typically large local and systemic reactions. For management of overdose reactions, refer to the ADVERSE REACTIONS section above.

  • DOSAGE AND ADMINISTRATION

    Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

    Skin test techniques for immediate (Type I) hypersensitivity testing fall into two major categories: percutaneous, and intracutaneous.

    Percutaneous techniques:

    For percutaneous testing, in general, skin is scratched, punctured or pricked just before the allergen is applied or through a drop of test allergen. There are several devices available for this technique. Refer to the manufacturer or distributor’s circular for specific directions for their use.

    In General:

    1. It is recommended that the test areas should be placed no closer than 4 - 5 cm apart to avoid interference of reactions when several tests are applied.
    2. Skin test areas should be cleansed with alcohol and air dried.
    3. Preferably, the allergen should be placed on the volar surface of the forearm, upper arm, or the patient’s back. The patient should be placed in a comfortable position prior to testing.
    4. For scratch testing, a sharp, clean, sterile instrument is used to abrade the skin, but not to draw blood. Each scratch should be about 2 - 4 mm in length. A small drop of extract is placed on the surface of the skin.
    5. Prick testing: For prick testing, a sharp, sterile instrument is used to puncture the skin slightly, applying it at a 15 - 20° angle to the skin. The instrument is gently raised, “tenting” the skin until it pops out, generally pricking through the drop of allergen. Do not draw blood.
    6. For puncture testing, a sharp, clean, sterile instrument must be used. Puncture the skin, through the drop of allergen, perpendicular to the skin. Do not draw blood.

    For all of the above techniques, a separate instrument must be used for each patient; if the instrument is to be used to pass through the allergen, to avoid cross-contamination, a separate instrument is to be used for each allergen. The test should be read in 15 minutes, measuring both wheal size and erythema.

    Intracutaneous (intradermal) testing:

    General: Intradermal testing is more sensitive than percutaneous testing and its specificity is dependent on dose. Intradermal testing is not intended as an initial screen unless used in highly dilute solutions. Intradermal testing is usually reserved for allergens that have demonstrated either negative or equivocal percutaneous skin test response in the face of positive or unclear history.

    Intradermal testing of one allergen in several serial dilutions (beginning with the weakest to the more concentrated dilutions) may also be useful in assessing degree of patient sensitivity for the establishment of a safe starting dose for immunotherapy.

    Bulk extracts must be diluted for intradermal testing. Use of Sterile Diluent for Allergenic Extracts or Sterile Diluent for Allergenic Extracts Normal Saline with HSA (albumin saline) is recommended. Dilutions should be made with sterile disposable syringes using aseptic technique. Commonly 10 fold dilutions are used to achieve a desired concentration for intradermal testing and continuation of immunotherapy. For example, transferring 0.5 mL of a 10,000 PNU/mL extract into 4.5 mL of diluent will yield 5 mL of extract at 1,000 PNU/mL. For weight volume products, a 1:100 w/v dilution may be prepared from a 1:10 w/v by transferring 0.5 mL of the 1:10 w/v to 4.5 mL of dilutent. Prepare as many additional serial dilutions as necessary to reach the appropriate concentration. As a general rule intradermal strength should begin at no higher than 1/100 to 1/1000 of the percutaneous strength that resulted in a negative skin test reaction.

    1. It is recommended that the test areas should be spaced no less than 5 cm apart to avoid interference with adjacent allergen or control.
    2. Skin should be cleansed with alcohol and air dried.
    3. A sterile 1 mL or 1/2 mL syringe with a 26 - 30 gauge needle should be used. A separate sterile syringe should be used for each extract and each patient.
    4. Care should be taken to eliminate air bubbles from the syringe prior to injecting the test dose. It is suggested that not more than 6 - 10 allergens of each different type be used at any one time. Very sensitive patients may show rapid response.
    5. The skin is held tensely, and the needle is inserted almost parallel to the skin, beveled side up far enough to cover the beveled portion. Slowly inject sufficient extract to make a small bleb of approximately 5 mm in diameter (0.01 - 0.02 mL).
    6. Read the test results in 15 minutes.

    Selection of the proper strength for intracutaneous testing: A general rule for the prevention of untoward reactions, particularly in extremely sensitive patients, is to screen by percutaneous methods initially, and begin intradermal testing at a strength not more than 1/100 of a negative or equivocal percutaneous reaction.

    Controls:

    In both percutaneous and intracutaneous tests, a negative control test with diluent alone should be performed because some patients exhibit dermographia, and/or other non-specific irritant responses.

    As a positive control in the evaluation of allergenic skin testing, histamine 1 mg/mL (histamine base) should be used for percutaneous testing, and histamine 0.1 mg/mL (histamine base) should be used for intradermal testing.

    Interpretation of results:

    Patient’s response is graded on the basis of the size of erythema or wheal.6 General guidelines follow for percutaneous testing, different devices and/or techniques influence the size of the reaction, therefore it is important to refer to the device manufacturer’s or distributor’s instructions when grading reactions.

    Percutaneous (prick or scratch) test:

    0       No reaction or less than control.

    +       Erythema greater than control, smaller than a nickel (21 mm diameter).

    ++       Erythema greater than a nickel in diameter, no wheal.

    +++ Wheal and erythema without pseudopods.

    ++++ Wheal and erythema with pseudopods.

    Intradermal test:

    0       No reaction or less than negative control.

    +       3-4 mm wheal with erythema, or erythema alone larger than a nickel (21 mm diameter).

    ++       4-8 mm wheal and erythema, without pseudopods.

    +++ Over 8 mm wheal and erythema without pseudopods.

    ++++ Wheal and erythema with pseudopods.

  • HOW SUPPLIED

    For scratch and prick testing: 5 mL dropper applicator vials in 50% v/v glycerin or 10mL stoppered vial in 50% v/v glycerin. Available individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v).

    For intracutaneous testing: 5 mL sterile vials, aqueous based, individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v).

    Histatrol® Positive skin test control - histamine. 1 mg/mL and 0.1 mg/mL histamine base.

    See Product Catalog for specific diagnostic concentrations available.

  • STORAGE

    To maintain stability of allergenic extracts, proper storage conditions are essential. Bulk concentrates and diluted extracts are to be stored at 2º to 8ºC even during use. Bulk or diluted extracts are not to be frozen. Do not use after the expiration date shown on the vial label.

  • REFERENCES

    1. Holgate, S.T., Robinson, C. and Church, M.K. Mediators of immediate hypersensitivity. In Middleton et al: Allergy Principles and Practice, St. Louis, 1988, C.V. Mosby, p 135.
    2. Lockey, R.F., et al. Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 1987: 79: 660.
    3. Reid, M.J. et al. Survey of fatalities from skin testing and immunotherapy. 1985-1989. J. Allergy Clin Immunol. 1993; 92:6.
    4. DeBuske L. M. et al. Special problems regarding Allergen Immunotherapy in Immunology and Allergy Clinics of North America, Greenburger, P.A. Ed. February 1992; 145-149.
    5. Bousquet, J. In vivo methods for the study of allergy: skin test, techniques and interpretation. In: Middleton et al.: Allergy Principles and Practice 3rd Ed. St. Louis: CV Mosby, 1988:167.
    6. Freedman, S.O. Asthma and Allergic Rhinitis II. Clinical Aspects, in Freedman and Gold Clinical Immunology 2nd Ed. New York: Harper & Row, 1976: 131.

    Revised  April 2017                   No. 112R      

    © ALK-Abelló, Inc.

    Distributed in Canada by:
    ALK-Abelló Pharmaceuticals, Inc.
    #35-151 Brunel Road
    Mississauga, Ontario
    Canada L4Z 2H6

  • PRINCIPAL DISPLAY PANEL

    ALLERGENIC EXTRACT
    DIN 00299987
    5mL sterile multiple dose vial
    FOR PERCUTANEOUS TESTING ONLY

    PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
DIN 00299987
5mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

  • PRINCIPAL DISPLAY PANEL

    ALLERGENIC EXTRACT
    DIN 00299987
    10mL sterile multiple dose vial
    FOR PERCUTANEOUS TESTING ONLY

    PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
DIN 00299987
10mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

  • INGREDIENTS AND APPEARANCE
    ALMOND 
    prunus dulcis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6100
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G) ALMOND0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6100-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6100-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    APPLE 
    malus domestica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6101
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9) APPLE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6101-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6101-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    APRICOT 
    prunus armeniaca injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6102
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    APRICOT (UNII: 269CJD5GZ9) (APRICOT - UNII:269CJD5GZ9) APRICOT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6102-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6102-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    ASPARAGUS 
    asparagus officinalis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6103
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ASPARAGUS (UNII: Z1EJP3037Z) (ASPARAGUS - UNII:Z1EJP3037Z) ASPARAGUS0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6103-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6103-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    AVOCADO 
    persea americana injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6104
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AVOCADO (UNII: SDS87L369F) (AVOCADO - UNII:SDS87L369F) AVOCADO0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6104-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6104-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BANANA 
    musa sapientum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6105
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BANANA (UNII: 4AJZ4765R9) (BANANA - UNII:4AJZ4765R9) BANANA0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6105-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6105-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BARLEY 
    hordeum vulgare injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6106
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6106-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6106-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BEEF 
    bos taurus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6109
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BEEF (UNII: 4PIB2155QP) (BEEF - UNII:4PIB2155QP) BEEF0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6109-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6109-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BELL PEPPER 
    capsicum annuum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6197
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GREEN BELL PEPPER (UNII: 4J4DOU3HEK) (GREEN BELL PEPPER - UNII:4J4DOU3HEK) GREEN BELL PEPPER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6197-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6197-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BLACK PEPPER 
    piper nigrum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6198
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6198-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6198-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BRAZIL NUT 
    bertholletia excelsa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6110
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BRAZIL NUT (UNII: XKR79OET1K) (BRAZIL NUT - UNII:XKR79OET1K) BRAZIL NUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6110-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6110-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BROCCOLI 
    brassica oleracea var. botrytis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6112
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BROCCOLI (UNII: UOI4FT57BZ) (BROCCOLI - UNII:UOI4FT57BZ) BROCCOLI0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6112-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6112-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    BUCKWHEAT 
    fagopyrum esculentum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6113
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6113-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6113-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CABBAGE 
    brassica oleracea var. capitata injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6114
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CABBAGE (UNII: GW0W1Y9I97) (CABBAGE - UNII:GW0W1Y9I97) CABBAGE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6114-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6114-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CANTALOUPE 
    cucumis melo cantalupensis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6115
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CANTALOUPE (UNII: 8QF5D5H6UH) (CANTALOUPE - UNII:8QF5D5H6UH) CANTALOUPE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6115-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6115-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CARROT 
    daucus carota injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6116
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CARROT (UNII: L56Z1JK48B) (CARROT - UNII:L56Z1JK48B) CARROT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6116-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6116-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CASEIN 
    bos taurus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6118
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CASEIN (UNII: 48268V50D5) (CASEIN - UNII:48268V50D5) CASEIN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6118-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6118-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CELERY 
    apium graveolens injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6120
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CELERY (UNII: 44IDY6DTKX) (CELERY - UNII:44IDY6DTKX) CELERY0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6120-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6120-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CHERRY 
    prunus avium injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6121
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SWEET CHERRY (UNII: 93T4562ZI3) (SWEET CHERRY - UNII:93T4562ZI3) SWEET CHERRY0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6121-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6121-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CHICKEN MEAT 
    gallus gallus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6122
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHICKEN (UNII: 0X8Q245Y7B) (CHICKEN - UNII:0X8Q245Y7B) CHICKEN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6122-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6122-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CINNAMON 
    cinnamomum verum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6123
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CINNAMON (UNII: 5S29HWU6QB) (CINNAMON - UNII:5S29HWU6QB) CINNAMON0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6123-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6123-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CLAM 
    mercenaria mercenaria injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6124
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NORTHERN QUAHOG (UNII: D6G49OV9IM) (NORTHERN QUAHOG - UNII:D6G49OV9IM) NORTHERN QUAHOG0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6124-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6124-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    COCOA BEAN 
    theobroma cacao injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6125
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COCOA (UNII: D9108TZ9KG) (COCOA - UNII:D9108TZ9KG) COCOA0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6125-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6125-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    COCONUT 
    cocos nucifera injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6127
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY) COCONUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6127-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6127-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CODFISH 
    gadus morhua injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6128
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6128-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6128-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    COFFEE 
    coffee arabica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6129
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ARABICA COFFEE BEAN (UNII: 3SW678MX72) (ARABICA COFFEE BEAN - UNII:3SW678MX72) ARABICA COFFEE BEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6129-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6129-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    COWS MILK 
    bos taurus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6178
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SKIM MILK (UNII: 6A001Y4M5A) (SKIM MILK - UNII:6A001Y4M5A) SKIM MILK0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6178-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6178-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CRAB 
    paralithodes camtschaticus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6130
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6130-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6130-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    CUCUMBER 
    cucumis sativus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6132
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CUCUMBER (UNII: YY7C30VXJT) (CUCUMBER - UNII:YY7C30VXJT) CUCUMBER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6132-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6132-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    EGG WHITE 
    gallus gallus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6133
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EGG WHITE (UNII: 3E0I92Z2GR) (EGG WHITE - UNII:3E0I92Z2GR) EGG WHITE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6133-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6133-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    EGG YOLK 
    gallus gallus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6136
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EGG YOLK (UNII: 4IPS17B70T) (EGG YOLK - UNII:4IPS17B70T) EGG YOLK0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6136-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6136-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    EGG, WHOLE 
    gallus gallus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6135
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EGG (UNII: 291P45F896) (EGG - UNII:291P45F896) EGG0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6135-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6135-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    ENGLISH WALNUT 
    juglans regia injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6231
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7) ENGLISH WALNUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6231-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6231-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    FLOUNDER 
    paralichthys dentatus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6137
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6137-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6137-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    GARLIC 
    allium sativum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6138
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6138-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6138-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    GOATS MILK 
    capra aegagrus hircus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6177
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GOAT MILK (UNII: XE5K5I4RP7) (GOAT MILK - UNII:XE5K5I4RP7) GOAT MILK0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6177-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6177-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    GRAPEFRUIT 
    citrus x paradisi injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6141
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT0.10 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6141-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375301/01/1965
    GREEN PEA 
    pisum sativum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6191
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PEA (UNII: W4X7H8GYFM) (PEA - UNII:W4X7H8GYFM) PEA0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6191-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6191-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    HALIBUT 
    hippoglossus hippoglossus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-7130
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-7130-065 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375301/01/1965
    HALIBUT 
    atlantic halibut injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6236
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6236-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375301/01/1965
    HONEYDEW 
    cucumis melo injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6146
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HONEYDEW MELON (UNII: RN8P45F92A) (HONEYDEW MELON - UNII:RN8P45F92A) HONEYDEW MELON0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6146-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6146-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    KIDNEY BEAN 
    phaseolus vulgaris injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6107
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6107-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6107-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    LAMB 
    ovis aries injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6149
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LAMB (UNII: FOF26T73HA) (LAMB - UNII:FOF26T73HA) LAMB0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6149-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6149-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    LEMON 
    citrus limon injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6170
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEMON (UNII: 24RS0A988O) (LEMON - UNII:24RS0A988O) LEMON0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6170-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6170-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    LETTUCE 
    lactuca sativa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6171
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LETTUCE (UNII: 5PO6NN3RRJ) (LETTUCE - UNII:5PO6NN3RRJ) LETTUCE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6171-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6171-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    LIMA BEAN 
    phaseolus lunatus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6173
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIMA BEAN (UNII: 112YH1ZMX2) (LIMA BEAN - UNII:112YH1ZMX2) LIMA BEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6173-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6173-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    LOBSTER 
    homarus americanus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6174
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6174-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6174-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    MIXED FISH 
    paralichthys dentatus, gadus morhua, hippoglossus hippoglossus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8043
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
    ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
    SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-8043-065 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375301/01/1965
    MIXED FISH 
    paralichthys dentatus, gadus morhua, hippoglossus hippoglossus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8044
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
    ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
    SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-8044-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375301/01/1965
    MIXED SHELLFISH 
    paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8061
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
    COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
    AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
    EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-8061-065 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    MIXED SHELLFISH 
    paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8062
    Route of AdministrationSUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
    COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
    AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
    EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-8062-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    MUSHROOM 
    agaricus campestris injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6180
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CULTIVATED MUSHROOM (UNII: 54C8E6W6JY) (CULTIVATED MUSHROOM - UNII:54C8E6W6JY) CULTIVATED MUSHROOM0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6180-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6180-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    MUSTARD 
    sinapis alba injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6181
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    WHITE MUSTARD SEED (UNII: 25VR943RPP) (WHITE MUSTARD SEED - UNII:25VR943RPP) WHITE MUSTARD SEED0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6181-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6181-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    OAT GRAIN 
    avena sativa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6183
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AVENA SATIVA WHOLE (UNII: 5P8D0Z74RG) (AVENA SATIVA WHOLE - UNII:5P8D0Z74RG) AVENA SATIVA WHOLE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6183-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6183-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    OLIVE 
    olea europaea injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6185
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BLACK OLIVE (UNII: 2M6QWV94OC) (BLACK OLIVE - UNII:2M6QWV94OC) BLACK OLIVE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6185-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6185-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    ONION 
    allium cepa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6186
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ONION (UNII: 492225Q21H) (ONION - UNII:492225Q21H) ONION0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6186-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6186-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    ORANGE 
    citrus x sinensis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6187
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ORANGE (UNII: 5EVU04N5QU) (ORANGE - UNII:5EVU04N5QU) ORANGE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6187-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6187-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    OYSTER 
    crassostrea virginica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6189
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6189-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6189-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PEACH 
    prunus persica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6192
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PEACH (UNII: 3OKE88I3QG) (PEACH - UNII:3OKE88I3QG) PEACH0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6192-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6192-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PEANUT 
    arachis hypogaea injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6193
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R) PEANUT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6193-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6193-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PEAR 
    pyrus communis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6195
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PEAR (UNII: 2ZN8DWC0YF) (PEAR - UNII:2ZN8DWC0YF) PEAR0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6195-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6195-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PECAN NUT 
    carya illinoinensis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6196
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F) PECAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6196-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6196-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PINEAPPLE 
    ananas comosus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6200
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PINEAPPLE (UNII: 2A88ZO081O) (PINEAPPLE - UNII:2A88ZO081O) PINEAPPLE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6200-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6200-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PISTACHIO NUT 
    pistacia vera injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6202
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PISTACHIO (UNII: 6815CPT6ZJ) (PISTACHIO - UNII:6815CPT6ZJ) PISTACHIO0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6202-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6202-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PLUM 
    prunus domestica injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6203
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PLUM (UNII: 67M3EQ6BE1) (PLUM - UNII:67M3EQ6BE1) PLUM0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6203-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6203-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    PORK 
    sus scrofa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6204
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PORK (UNII: O138UB266J) (PORK - UNII:O138UB266J) PORK0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6204-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6204-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    RICE 
    oryza sativa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6208
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    WHITE RICE (UNII: A195V20H7A) (WHITE RICE - UNII:A195V20H7A) WHITE RICE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6208-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6208-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    RYE GRAIN 
    secale cereale injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6210
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RYE (UNII: 0R4AQI398X) (RYE - UNII:0R4AQI398X) RYE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6210-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6210-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SALMON 
    salmo salar injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6212
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATLANTIC SALMON (UNII: 7062I37LB3) (ATLANTIC SALMON - UNII:7062I37LB3) ATLANTIC SALMON0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6212-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6212-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SESAME SEED 
    sesamum indicum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6213
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SESAME SEED (UNII: 7Y1255HVXR) (SESAME SEED - UNII:7Y1255HVXR) SESAME SEED0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6213-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6213-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SHRIMP 
    crangon crangon injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6214
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6214-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6214-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SOYBEAN 
    glycine max injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6216
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SOYBEAN (UNII: L7HT8F1ZOD) (SOYBEAN - UNII:L7HT8F1ZOD) SOYBEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6216-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6216-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SPINACH 
    spinacia oleracea injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6218
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SPINACH (UNII: 6WO75C6WVB) (SPINACH - UNII:6WO75C6WVB) SPINACH0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6218-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6218-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SQUASH 
    curcubita pepo injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6219
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ZUCCHINI (UNII: EQU1BON34S) (ZUCCHINI - UNII:EQU1BON34S) ZUCCHINI0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6219-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6219-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    STRAWBERRY 
    fragaria x ananassa injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6220
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    STRAWBERRY (UNII: 4J2TY8Y81V) (STRAWBERRY - UNII:4J2TY8Y81V) STRAWBERRY0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6220-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6220-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    STRINGBEAN 
    phaseolus vulgaris injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6108
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    STRING BEAN (UNII: N9D69B2Q7Y) (STRING BEAN - UNII:N9D69B2Q7Y) STRING BEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6108-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6108-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SWEET CORN 
    zea mays injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6221
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CORN (UNII: 0N8672707O) (CORN - UNII:0N8672707O) CORN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6221-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6221-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    SWEET POTATO 
    ipomoea batatas injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6205
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SWEET POTATO (UNII: M9WGG9Z9GK) (SWEET POTATO - UNII:M9WGG9Z9GK) SWEET POTATO0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6205-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6205-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    THEA SINENSIS 
    thea sinensis injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6235
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24) TEA LEAF0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6235-065 mL in 1 VIAL; Type 0: Not a Combination Product
    2NDC:0268-6235-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    TOMATO 
    solanum lycopersicum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6224
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TOMATO (UNII: Z4KHF2C175) (TOMATO - UNII:Z4KHF2C175) TOMATO0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6224-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6224-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    TUNA 
    thunnus thynnus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6226
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NORTHERN BLUEFIN TUNA (UNII: 816CLQ4017) (NORTHERN BLUEFIN TUNA - UNII:816CLQ4017) NORTHERN BLUEFIN TUNA0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6226-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6226-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    TURKEY 
    meleagris gallopavo injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6229
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TURKEY (UNII: 8E9NT44R8I) (TURKEY - UNII:8E9NT44R8I) TURKEY0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6229-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6229-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    VANILLA 
    vanilla planifolia injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6230
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    VANILLA BEAN (UNII: Q74T35078H) (VANILLA BEAN - UNII:Q74T35078H) VANILLA BEAN0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6230-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6230-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    VITIS SPP 
    vitis spp injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6139
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GRAPE (UNII: 6X543N684K) (GRAPE - UNII:6X543N684K) GRAPE0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6139-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6139-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    WATERMELON 
    citrullus lanatus injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6233
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    WATERMELON (UNII: 231473QB6R) (WATERMELON - UNII:231473QB6R) WATERMELON0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6233-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    2NDC:0268-6233-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    WHEAT GRAIN 
    triticum aestivum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6234
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    WHEAT (UNII: 4J2I0SN84Y) (WHEAT - UNII:4J2I0SN84Y) WHEAT0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6234-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6234-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    WHITE POTATO 
    solanum tuberosum injection, solution
    Product Information
    Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6206
    Route of AdministrationPERCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POTATO (UNII: CFE1S8DYWD) (POTATO - UNII:CFE1S8DYWD) POTATO0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOL (UNII: 339NCG44TV)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0268-6206-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2NDC:0268-6206-1010 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BLABLA10375302/23/1998
    Labeler - ALK-Abello, Inc. (809998847)